$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

$areb Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041007 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$4.810M	$3.346M	$4.103M
YoY Change	24.8%	-18.46%	1288.46%
Cost Of Revenue	$4.322M	$3.095M	$3.125M
YoY Change	41.86%	-0.94%	1015.11%
Gross Profit	$487.6K	$250.1K	$978.1K
YoY Change	-39.6%	-74.43%	6301.2%
Gross Profit Margin	10.14%	7.48%	23.84%
Selling, General & Admin	$3.276M	$2.617M	$2.619M
YoY Change	331.19%	-0.1%	193.13%
% of Gross Profit	671.88%	1046.11%	267.79%
Research & Development	$426.0K	$20.33K
YoY Change	-43.84%
% of Gross Profit	87.37%	8.13%
Depreciation & Amortization	$24.97K	$29.26K	$9.950K
YoY Change	-35.61%	194.07%	631.62%
% of Gross Profit	5.12%	11.7%	1.02%
Operating Expenses	$3.727M	$3.179M	$2.748M
YoY Change	139.36%	15.68%	182.79%
Operating Profit	-$3.240M	-$2.929M	-$1.770M
YoY Change	332.03%	65.46%	85.06%
Interest Expense	-$154.8K	$95.33K	$31.58K
YoY Change	895.5%	201.83%	-108.26%
% of Operating Profit
Other Income/Expense, Net	$5.670K	$135.4K	-$377.2K
YoY Change		-135.91%	-19.78%
Pretax Income	-$7.490M	-$2.794M	-$2.147M
YoY Change	878.53%	30.1%	50.51%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$7.490M	-$2.794M	-$2.147M
YoY Change	878.53%	30.1%	50.51%
Net Earnings / Revenue	-155.71%	-83.5%	-52.34%
Basic Earnings Per Share		-$0.95	-$0.36
Diluted Earnings Per Share	-$1.02	-$0.95	-$356.0K
COMMON SHARES
Basic Shares Outstanding	5.020M shares	2.842M shares	5.251M shares
Diluted Shares Outstanding		2.931M shares	241.3K shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.148M	$1.633M	$1.186M
YoY Change	221.71%	37.76%	443.02%
Cash & Equivalents	$1.148M	$1.633M	$1.186M
Short-Term Investments
Other Short-Term Assets	$190.9K	$166.1K	$147.8K
YoY Change	-7.79%	12.39%	-9.58%
Inventory	$6.103M	$8.821M	$6.537M
Prepaid Expenses	$190.9K	$166.1K	$147.8K
Receivables	$2.817M	$2.631M	$2.446M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.26M	$13.25M	$10.32M
YoY Change	3.53%	28.45%	678.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.307M	$377.3K	$486.1K
YoY Change	405.35%	-22.38%	26903.89%
Goodwill	$2.000M	$4.525M
YoY Change	-52.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$83.40K	$5.822M	$4.220M
YoY Change	-98.65%	37.97%
Total Long-Term Assets	$4.390M	$6.199M	$4.706M
YoY Change	-34.0%	31.73%	261327.94%
TOTAL ASSETS
Total Short-Term Assets	$10.26M	$13.25M	$10.32M
Total Long-Term Assets	$4.390M	$6.199M	$4.706M
Total Assets	$14.65M	$19.45M	$15.02M
YoY Change	-11.54%	29.48%	1031.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.979M	$2.174M	$2.312M
YoY Change	-21.59%	-5.98%	212.53%
Accrued Expenses	$1.310M	$827.1K	$67.92K
YoY Change	19.49%	1117.7%	-76.39%
Deferred Revenue
YoY Change
Short-Term Debt	$3.456M	$1.153M	$603.8K
YoY Change	473.55%	90.94%	-83.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.745M	$5.938M	$2.988M
YoY Change	59.74%	98.74%	-35.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$907.5K	$439.5K
YoY Change	-7.85%
Total Long-Term Liabilities	$907.5K	$439.5K	$0.00
YoY Change	-7.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.745M	$5.938M	$2.988M
Total Long-Term Liabilities	$907.5K	$439.5K	$0.00
Total Liabilities	$7.653M	$6.378M	$2.988M
YoY Change	46.96%	113.45%	-35.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$45.21M	-$37.72M	-$33.35M
YoY Change	32.54%	13.12%
Common Stock	$9.005K	$5.875K	$8.474K
YoY Change	-46.81%	-30.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.996M	$13.07M	$12.03M
YoY Change
Total Liabilities & Shareholders Equity	$14.65M	$19.45M	$15.02M
YoY Change	-11.54%	29.48%	1031.71%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$7.490M	-$2.794M	-$2.147M
YoY Change	878.53%	30.1%	50.51%
Depreciation, Depletion And Amortization	$24.97K	$29.26K	$9.950K
YoY Change	-35.61%	194.07%	631.62%
Cash From Operating Activities	-$946.8K	-$3.619M	-$2.024M
YoY Change	5.11%	78.86%	232.81%
INVESTING ACTIVITIES
Capital Expenditures	$6.300K		$0.00
YoY Change	-12.98%
Acquisitions
YoY Change
Other Investing Activities	-$51.40K	-$273.6K	-$10.25M
YoY Change		-97.33%
Cash From Investing Activities	-$57.70K	-$273.6K	-$10.25M
YoY Change	696.96%	-97.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	519.0K	2.789M	10.95M
YoY Change	555.23%	-74.52%	1858.38%
NET CHANGE
Cash From Operating Activities	-946.8K	-3.619M	-2.024M
Cash From Investing Activities	-57.70K	-273.6K	-10.25M
Cash From Financing Activities	519.0K	2.789M	10.95M
Net Change In Cash	-485.5K	-1.104M	-1.324M
YoY Change	-41.42%	-16.68%	2600.63%
FREE CASH FLOW
Cash From Operating Activities	-$946.8K	-$3.619M	-$2.024M
Capital Expenditures	$6.300K		$0.00
Free Cash Flow	-$953.1K		-$2.024M
YoY Change	4.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001648087
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease		usd
CY2023Q3	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
CY2022Q3	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease		usd
	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	AREB	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired		usd
	AREB	Partial Payment Made On Settlement Of Outstanding Liability Champion Entities Purchase PartialPaymentMadeOnSettlementOfOutstandingLiabilityChampionEntitiesPurchase		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q3	AREB	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2023Q3	AREB	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue		usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41267
	dei	Entity Registrant Name EntityRegistrantName	AMERICAN REBEL HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3892903
	dei	Entity Address Address Line1 EntityAddressAddressLine1	909 18th Avenue South
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37212
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	267-3235
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5019920	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633238	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	356754	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	2631439	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1613489	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	166137	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	207052	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8509992	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	310587	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	309684	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	13251393	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9908675	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	377264	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
CY2023Q3	us-gaap	Deposit Assets DepositAssets	59106	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	18032	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1237618	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1977329	usd
CY2023Q3	us-gaap	Goodwill Goodwill	4525000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5821724	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6195361	usd
CY2023Q3	us-gaap	Assets Assets	19450381	usd
CY2022Q4	us-gaap	Assets Assets	16560561	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2173725	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2523551	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	28919	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	103919	usd
CY2023Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	95332	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1152972	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1689163	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	798136	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	992496	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5938247	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4222609	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	439482	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	984833	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6377729	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5207442	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5875263	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5875263	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	677221	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	677221	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	5875	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	677	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50790341	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45465077	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37723739	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13072652	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19450381	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16560561	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3345552	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4102761	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	3095418	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3124657	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	250134	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	978104	usd
CY2023Q3	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1039273	usd
CY2022Q3	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1227953	usd
CY2023Q3	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	230226	usd
CY2022Q3	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	314314	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20326	usd
CY2023Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	517345	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	119122	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1347181	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1077005	usd
CY2023Q3	AREB	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	24895	usd
CY2022Q3	AREB	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	9956	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3179246	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2748350	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2929112	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1770246	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	95330	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	31584	usd
CY2022Q3	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease	350000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3203	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4428	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	227569	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	135442	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-377156	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2793670	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2147402	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2793670	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2147402	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.90
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.90
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2930700	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2930700	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	241300	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	241300	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11418222	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4595547	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8869432	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3462454	usd
	us-gaap	Gross Profit GrossProfit	2548790	usd
	us-gaap	Gross Profit GrossProfit	1133093	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	2915377	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1937349	usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	732360	usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	314314	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36821	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	146463	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	942687	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	349341	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2542181	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2687728	usd
	AREB	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	79260	usd
	AREB	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	11311	usd
	us-gaap	Operating Expenses OperatingExpenses	7248686	usd
	us-gaap	Operating Expenses OperatingExpenses	5446506	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4699896	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4313413	usd
	us-gaap	Interest Expense InterestExpense	250877	usd
	us-gaap	Interest Expense InterestExpense	341990	usd
	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease	350000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3203	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4428	usd
	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect	1107672	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1030535	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000457	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1017950	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	227569	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1376756	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1088967	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2064318	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3610929	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6377731	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3610929	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.50
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-33.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-33.62
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1442600	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1442600	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	189700	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	189700	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170337	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9038456	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	969535	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1566559	usd
	AREB	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne	565335	usd
	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	12322542	usd
	AREB	Adjustments To Additional Paid In Capital Offering Costs And Fees Associated With Offering AdjustmentsToAdditionalPaidInCapitalOfferingCostsAndFeesAssociatedWithOffering	-1972578	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	61000	usd
	AREB	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	31234	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12033975	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	312452	usd
	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	2681400	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-529324	usd
	AREB	Warrant Inducement Shares Exercised WarrantInducementSharesExercised	2988687	shares
	AREB	Stock Issued During Period Value Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodValueWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	3287556	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	453756	usd
	AREB	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	6150	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25984	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3610929	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13072652	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	13072652	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3610929	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79260	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11311	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	25984	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	219697	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-40915	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-20184	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1089198	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	869985	usd
	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	41074	usd
	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	224894	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-474827	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-297513	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6089219	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5927333	usd
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	10247420	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1402	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	13651	usd
	AREB	Partial Payment Made On Settlement Of Outstanding Liability Champion Entities Purchase PartialPaymentMadeOnSettlementOfOutstandingLiabilityChampionEntitiesPurchase	275000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273598	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10261071	usd
	AREB	Payments Of Net Offering Costs PaymentsOfNetOfferingCosts	983080	usd
	AREB	Payments Of Net Offering Costs PaymentsOfNetOfferingCosts	3434122	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5298330	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19953755	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6150	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	31234	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1700000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10837	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	95332	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-81506	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1000000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	60000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	449675	usd
	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt	2607108	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7639300	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17356375	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1276483	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1167971	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	356754	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17607	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1633238	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1185578	usd
	us-gaap	Interest Paid Net InterestPaidNet	245874	usd
	us-gaap	Interest Paid Net InterestPaidNet	234146	usd
	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock	2011224	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2014-12-15
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_841_eus-gaap--FiscalPeriod_zp4Mu2oluGwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zSkxG9gIR2S5">Year-end</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	172617	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	119122	usd
	us-gaap	Advertising Expense AdvertisingExpense	942687	usd
	us-gaap	Advertising Expense AdvertisingExpense	349341	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.90
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.90
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.50
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-33.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-33.62
	AREB	Shares Used In Computation Of Basic Earnings Per Share SharesUsedInComputationOfBasicEarningsPerShare	1442600	shares
	AREB	Shares Used In Computation Of Basic Earnings Per Share SharesUsedInComputationOfBasicEarningsPerShare	189700	shares
	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	1714700	shares
	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	344000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3157300	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	533700	shares
	us-gaap	Net Income Loss NetIncomeLoss	-3610929	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
	AREB	Fully Diluted Income Loss Per Share FullyDilutedIncomeLossPerShare	-1.14
	AREB	Fully Diluted Income Loss Per Share FullyDilutedIncomeLossPerShare	-11.95
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zcnbFbBCe8Q1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_ziZ04j447Go4">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	AREB	Warranty Liability WarrantyLiability	100000	usd
CY2022Q4	AREB	Warranty Liability WarrantyLiability	100000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7731380	usd
CY2022Q4	us-gaap	Deposits Deposits	600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3610929	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37723739	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q3	AREB	Working Capital Deficit WorkingCapitalDeficit	8111282	usd
CY2022Q4	AREB	Working Capital Deficit WorkingCapitalDeficit	6678562	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8509992	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q3	AREB	Inventory Deposits InventoryDeposits	310587	usd
CY2022Q4	AREB	Inventory Deposits InventoryDeposits	309684	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	8820579	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	790832	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	815859	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	413568	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	359334	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	377264	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
	us-gaap	Depreciation Depreciation	79260	usd
	us-gaap	Depreciation Depreciation	11311	usd
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P60M
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1689163	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1689163	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	600000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	600000	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1152972	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1152972	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q3	AREB	Working Capital Loan WorkingCapitalLoan	600000	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1152972	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q3	us-gaap	Goodwill Goodwill	4525000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4500000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	37723739	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34112810	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7922000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7163690	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7922000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7163690	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7922000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7922000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	As a result, management determined it was more likely than not deferred tax assets will not be realized as of September 30, 2023, and December 31, 2022, and recognized 100% valuation allowance for each period
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q3	AREB	Corporate Alternative Minimum Income Tax Rate CorporateAlternativeMinimumIncomeTaxRate	0.15	pure
CY2022Q3	AREB	Percentage Of Excise Tax On Corporate Stock Repurchases PercentageOfExciseTaxOnCorporateStockRepurchases	0.01	pure
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-25
	AREB	Stock Issued During Period Shares Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodSharesWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	2988687	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2902.38	usd
CY2023Q3	AREB	Gain On Settlement Of Debt GainOnSettlementOfDebt	228000	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	129.6875
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1566659.00	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15099	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15099	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	129.6875
CY2022Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	12887976.31	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	20372	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	27.50
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2993850.63	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	71499	shares
CY2023Q2	us-gaap	Share Price SharePrice	4.37
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	615000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.37
	AREB	Stock Issued During Period Shares Warrant Inducement And Exercise Of Repriced Common Stock Warrants Per Share StockIssuedDuringPeriodSharesWarrantInducementAndExerciseOfRepricedCommonStockWarrantsPerShare	2988687	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2022Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	15099	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	28072	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	220.00
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	116386	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	50.25
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2022	AREB	Share Based Payment Award Options Granted Debt Conversion ShareBasedPaymentAwardOptionsGrantedDebtConversion	15099	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Debt Conversion Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedDebtConversionExercisePrice	50.25
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Granted Debt Conversion Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualGrantedDebtConversionTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWarrant	463195	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Warrant Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageWarrantExercisePrice	0.25
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne	936937	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price One ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne	21.50
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	463195	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.25
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	39	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1096455	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.05
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M12D
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWarrant	615000	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Warrant Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageWarrantExercisePrice	4.37
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P5Y
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne	686499	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.24
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther	1365251	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Repricing Transaction ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRepricingTransaction	1.10
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm3	P4Y
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted New Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedNewWarrant	5977374	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Agreement New Warrants ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedAgreementNewWarrants	1.10
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term4 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm4	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	3603687	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.88
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Exercised Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageExercisedRemainingContractualTerm2	P5Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	6136892	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Agreement New Warrants ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedAgreementNewWarrants	1.10
	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	630000	usd
	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	300000	usd
	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	632420	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	632420	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1237618	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	739710	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	265965	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	688526	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	163794	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	62792	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3733	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1184810	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	46410	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1138330	usd
	us-gaap	Payments For Rent PaymentsForRent	630000	usd
	us-gaap	Payments For Rent PaymentsForRent	300000	usd
CY2023Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1689163	usd

Files In Submission

Name	View Source	Status
0001493152-23-041007-index-headers.html	Edgar Link	pending
0001493152-23-041007-index.html	Edgar Link	pending
0001493152-23-041007.txt	Edgar Link	pending
0001493152-23-041007-xbrl.zip	Edgar Link	pending
areb-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
areb-20230930_def.xml	Edgar Link	unprocessable
areb-20230930_cal.xml	Edgar Link	unprocessable
areb-20230930_pre.xml	Edgar Link	unprocessable
areb-20230930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

2023 Q4 Form 10-Q Financial Statement

#000149315223041007 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB AMERICAN REBEL HOLDINGS INC Stock $areb

2023 Q4 Form 10-Q Financial Statement

#000149315223041007 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb